See more : Clas Ohlson AB (publ) (CLAS-B.ST) Income Statement Analysis – Financial Results
Complete financial analysis of Advanced Human Imaging Limited (AHI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Advanced Human Imaging Limited, a leading company in the Software – Application industry within the Technology sector.
- aReit Prop Limited (APO.JO) Income Statement Analysis – Financial Results
- Kingston Resources Limited (KSN.AX) Income Statement Analysis – Financial Results
- Yamaki Co.,Ltd. (3598.T) Income Statement Analysis – Financial Results
- Britannia Industries Limited (BRITANNIA.NS) Income Statement Analysis – Financial Results
- RELX PLC (RDEB.DE) Income Statement Analysis – Financial Results
Advanced Human Imaging Limited (AHI)
About Advanced Human Imaging Limited
Advanced Human Imaging Limited operates as a mobile application and technology development company worldwide. It develops and patents a proprietary measurement/dimensioning technology that enables end-user to check, track, and assess body dimensions privately using a smartphone. The company offers smartphone-based human scanning technology, such as BodyScan, FaceScan, DermaScan, MKScan, and HemaScan. It serves mobile health and telehealth, life and health insurance, fitness and wellness, and consumer apparel sectors. The company was formerly known as MyFiziq Limited and changed its name to Advanced Human Imaging Limited in March 2021. Advanced Human Imaging Limited was incorporated in 2014 and is based in South Perth, Australia.
Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 368.43K | 654.84K | 271.01K | 611.65K | 246.34K | 153.30K | 1.70M | 34.88K | 0.00 | 7.02K |
Cost of Revenue | 368.43K | 5.33M | 11.76M | 9.89M | 3.90M | 3.82M | 14.48M | 1.62M | 1.11M | 225.05K |
Gross Profit | 0.00 | -4.67M | -11.49M | -9.27M | -3.65M | -3.67M | -12.77M | -1.58M | -1.11M | -218.02K |
Gross Profit Ratio | 0.00% | -713.51% | -4,240.21% | -1,516.31% | -1,482.92% | -2,394.43% | -749.48% | -4,530.84% | 0.00% | -3,104.43% |
Research & Development | 0.00 | 25.29K | 164.05K | 235.86K | 171.74K | 171.74K | 194.70K | 0.00 | 78.54K | 2.19K |
General & Administrative | 0.00 | 5.68M | 4.44M | 1.69M | 1.42M | 927.73K | 988.48K | 614.86K | 648.92K | 276.71K |
Selling & Marketing | 0.00 | 910.40K | 2.11M | 1.45M | 1.27M | 331.74K | 347.31K | 403.35K | 310.21K | 378.70K |
SG&A | 7.42M | 6.59M | 7.89M | 3.14M | 2.69M | 1.63M | 1.82M | 1.34M | 1.15M | 657.53K |
Other Expenses | 0.00 | 0.00 | 0.00 | 770.99K | 671.33K | 893.82K | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 7.42M | 6.83M | 8.58M | 5.36M | 2.27M | 1.08M | 1.66M | 1.29M | 1.10M | 657.53K |
Cost & Expenses | 7.78M | 13.26M | 20.34M | 15.25M | 6.17M | 4.91M | 16.14M | 2.91M | 2.21M | 882.58K |
Interest Income | 227.31K | 254.39K | 8.57K | 208.54K | 143.57K | 136.51K | 7.47K | 48.02K | 100.96K | 0.00 |
Interest Expense | 688.45K | 477.68K | 163.82K | 250.67K | 143.58K | 136.60K | 9.85K | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 358.21K | 312.56K | 293.30K | 43.13K | 38.71K | 27.83K | 22.78K | 13.85K | 7.07K | 875.55K |
EBITDA | -7.05M | -11.57M | -19.45M | -14.25M | -5.67M | -5.47M | -14.41M | -2.86M | -2.20M | 0.00 |
EBITDA Ratio | -1,913.65% | -1,766.15% | -6,848.42% | -2,016.54% | -2,557.92% | -3,567.99% | -845.64% | -8,200.85% | 0.00% | 0.00% |
Operating Income | -7.41M | -12.60M | -18.85M | -12.38M | -6.34M | -5.50M | -14.43M | -2.87M | -2.21M | -875.55K |
Operating Income Ratio | -2,010.87% | -1,924.73% | -6,956.65% | -2,023.60% | -2,573.64% | -3,586.15% | -846.98% | -8,240.57% | 0.00% | -12,466.95% |
Total Other Income/Expenses | 3.26M | -890.48K | -8.57K | -208.54K | 277.27K | 757.31K | -8.15K | 48.02K | 100.96K | 0.00 |
Income Before Tax | -4.15M | -12.83M | -20.08M | -14.85M | -6.06M | -4.89M | -14.44M | -2.83M | -2.11M | -875.55K |
Income Before Tax Ratio | -1,125.70% | -1,958.83% | -7,408.21% | -2,427.10% | -2,461.08% | -3,189.11% | -847.46% | -8,102.88% | 0.00% | -12,466.95% |
Income Tax Expense | -4.15M | 0.00 | -890.11K | 784.41K | 666.22K | 531.64K | 521.73K | 636.35K | 70.14K | 0.00 |
Net Income | -4.15M | -12.83M | -20.08M | -14.06M | -5.40M | -4.36M | -13.92M | -2.19M | -2.04M | -875.55K |
Net Income Ratio | -1,125.70% | -1,958.83% | -7,408.21% | -2,298.85% | -2,190.64% | -2,842.30% | -816.84% | -6,278.27% | 0.00% | -12,466.95% |
EPS | -0.02 | -0.07 | -0.13 | -0.11 | -0.05 | -0.05 | -0.18 | -0.03 | -0.03 | -0.03 |
EPS Diluted | -0.02 | -0.07 | -0.13 | -0.11 | -0.05 | -0.05 | -0.18 | -0.03 | -0.03 | -0.03 |
Weighted Avg Shares Out | 208.10M | 184.84M | 153.49M | 125.50M | 104.62M | 84.45M | 79.04M | 78.20M | 75.36M | 32.11M |
Weighted Avg Shares Out (Dil) | 208.10M | 184.84M | 153.49M | 125.50M | 104.62M | 84.45M | 79.04M | 78.68M | 75.36M | 32.11M |
Advanced Health Intelligence Obtains Overseas R&D Reimbursement Under Australia's Research and Development Tax Incentive Scheme (R&DTI)
Advanced Health Intelligence to re-enter China with Exclusive License Deal with Changlin Network Technology Ltd
AHI Commentary for the Quarter Ended 30 June 2023
Advanced Health Intelligence stock rockets nearly 500% on massive volume, with no news reported
Why Is Advanced Health Intelligence (AHI) Stock Up 114% Today?
Wellteq Digital Health completes of plan of arrangement with Advanced Human Imaging
Wellteq Digital Health gets legal go-ahead for shareholder vote on acquisition by Advanced Human Imaging
Wellteq Digital Health agrees to acquisition by Australia's Advanced Human Imaging
Hot Penny Stocks To Buy For Under $5 Right Now
Source: https://incomestatements.info
Category: Stock Reports